Sanofi built Europe’s full mRNA chain. Now Brussels needs to deliver fast

EU PERSPECTIVES - Sanofi has reaffirmed its commitment to innovating 'from France for the world'. The pharma company announced at the recent Choose France Summit that it is consolidating or launching €1bn in new investments across the country in 2025–2026. Read more

A billion-euro business: mRNA by Sanofi / Photo: Sanofi